Scnn1a-flox Mouse
Common Name
Scnn1a-flox
제품 ID
S-CKO-17705
Backgroud
C57BL/6JCya
품종 계통계통 ID
CKOCMP-20276-Scnn1a-B6J-VC
상태
이 마우스 계통을 논문에서 사용할 경우, “Scnn1a-flox Mouse (카탈로그 번호 S-CKO-17705)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
기본 정보
품종 계통
Scnn1a-flox
품종 계통계통 ID
CKOCMP-20276-Scnn1a-B6J-VC
유전자명
제품 ID
S-CKO-17705
유전자 별칭
ENaC, SCNEA, Scnn1, mENaC
배경
C57BL/6JCya
NCBI ID
변형 내용
Conditional knockout
염색체
Chr 6
Phenotype
Datasheet
적용 분야
--
품종 계통 설명
Ensembl 전사체 ID
ENSMUST00000081440
NCBI 전사체 ID
NM_011324
타겟 영역
Exon 2
유효 영역 크기
~0.8 kb
유전자 연구 개요
Scnn1a, which encodes the α -subunit of the epithelial sodium channel (α -ENaC), plays a crucial role in regulating sodium absorption in epithelial tissues, such as those in the kidney, lung, and colon. This process is essential for maintaining fluid and electrolyte balance, blood pressure regulation, and normal organ function [2,5,6]. Dysregulation of Scnn1a can disrupt these physiological processes, leading to various health issues.
In terms of disease associations, mutations in Scnn1a can cause Liddle syndrome, an autosomal-dominant monogenic disease characterized by early-onset hypertension, hypokalaemia, and metabolic alkalosis [2]. Additionally, Scnn1a has been implicated in several cancers. In ovarian cancer, its overexpression is correlated with poor prognosis and immune cell infiltration, and it may play a role in cell growth, invasion, and migration through regulating epithelial-mesenchymal transformation [1,4]. In pancreatic cancer, Scnn1a overexpression is associated with TP53 mutation and unfavorable prognosis, and it exerts oncogenic functions by accelerating cellular growth and metastasis [3]. In triple-negative breast cancer, high Scnn1a expression is associated with poor prognosis and non-pathological complete response status following neoadjuvant chemotherapy [9]. A novel mutation in Scnn1a has also been found in a patient with autosomal-recessive pseudohypoaldosteronism type 1 [5], and SNPs in Scnn1a may be associated with neonatal respiratory distress syndrome, particularly in term infants [8]. miR-95 promotes osteosarcoma growth by targeting Scnn1a [7].
In conclusion, Scnn1a is vital for maintaining fluid and electrolyte balance through its role in sodium absorption. Its dysregulation, whether through mutation or altered expression, is associated with various diseases, including monogenic hypertension, pseudohypoaldosteronism, neonatal respiratory distress syndrome, and multiple types of cancer. Understanding the function of Scnn1a through genetic models could potentially lead to better diagnostic and therapeutic strategies for these conditions.
References:
1. Lou, Jiayan, Wei, Lingjia, Wang, He. 2022. SCNN1A Overexpression Correlates with Poor Prognosis and Immune Infiltrates in Ovarian Cancer. In International journal of general medicine, 15, 1743-1763. doi:10.2147/IJGM.S351976. https://pubmed.ncbi.nlm.nih.gov/35221714/
2. Tian, Jiajia, Xiang, Fei, Wang, Liandi, Ma, Li, Fang, Chuwen. 2024. Liddle Syndrome with a SCNN1A Mutation: A Case Report and Literature Review. In Kidney & blood pressure research, 49, 831-838. doi:10.1159/000540522. https://pubmed.ncbi.nlm.nih.gov/39236685/
3. Gao, Feng, Wang, Dan, Liu, Xun, Wang, Huai-Tao, Sun, Shao-Long. 2022. Sodium channel 1 subunit alpha SCNN1A exerts oncogenic function in pancreatic cancer via accelerating cellular growth and metastasis. In Archives of biochemistry and biophysics, 727, 109323. doi:10.1016/j.abb.2022.109323. https://pubmed.ncbi.nlm.nih.gov/35714697/
4. Wu, Lan, Ling, Zhong-Hui, Wang, Huan, Wang, Xin-Yan, Gui, Jing. 2019. Upregulation of SCNN1A Promotes Cell Proliferation, Migration, and Predicts Poor Prognosis in Ovarian Cancer Through Regulating Epithelial-Mesenchymal Transformation. In Cancer biotherapy & radiopharmaceuticals, 34, 642-649. doi:10.1089/cbr.2019.2824. https://pubmed.ncbi.nlm.nih.gov/31549859/
5. Huneif, Mohammed Ayed, Alhazmy, Ziyad Hamad, Shoomi, Anas M., Mushiba, Aziza M., AlSaheel, Abdulhamid. 2021. A Novel SCNN1A Variation in a Patient with Autosomal-recessive Pseudohypoaldosteronism Type 1. In Journal of clinical research in pediatric endocrinology, 14, 244-250. doi:10.4274/jcrpe.galenos.2021.2020.0175. https://pubmed.ncbi.nlm.nih.gov/33829730/
6. Serra, Gregorio, Antona, Vincenzo, D'Alessandro, Maria Michela, Verde, Vincenzo, Corsello, Giovanni. 2021. Novel SCNN1A gene splicing-site mutation causing autosomal recessive pseudohypoaldosteronism type 1 (PHA1) in two Italian patients belonging to the same small town. In Italian journal of pediatrics, 47, 138. doi:10.1186/s13052-021-01080-x. https://pubmed.ncbi.nlm.nih.gov/34134742/
7. Geng, Yannan, Zhao, Shaorong, Jia, Yutao, Zhang, Quan, Tian, Rong. 2020. miR‑95 promotes osteosarcoma growth by targeting SCNN1A. In Oncology reports, 43, 1429-1436. doi:10.3892/or.2020.7514. https://pubmed.ncbi.nlm.nih.gov/32323794/
8. Li, Wang, Long, Chen, Renjun, Li, Juan, Ma, Yuan, Shi. 2015. Association of SCNN1A Single Nucleotide Polymorphisms with neonatal respiratory distress syndrome. In Scientific reports, 5, 17317. doi:10.1038/srep17317. https://pubmed.ncbi.nlm.nih.gov/26611714/
9. Jin, Xin, Ge, Yue, Sun, Tongjun, Zhang, Ligong, Qian, Jun. 2025. SCNN1A expression in triple-negative breast cancer: clinical implications for prognosis and neoadjuvant therapy response. In World journal of surgical oncology, 23, 169. doi:10.1186/s12957-025-03698-1. https://pubmed.ncbi.nlm.nih.gov/40287704/
품질 관리 기준
정자 검사
동결 보존 전: 정자 농도 측정 및 정자 생존율 평가.
동결 보존 후: 각 배치에서 동결 보존된 정자 바이알 1개를 선택하여 체외수정(in vitro fertilization)에 사용합니다.
Environmental Standards:
SPFAvailable Region:
GlobalSource:
Cyagen문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
